Positions

Overview

  • I am an Assistant Professor of Radiation Oncology at the University of Alabama at Birmingham and am a member of the UAB Institute for Cancer Outcomes and Survivorship. My clinical specialization in genitourinary and gastrointestinal cancer and my clinician scientist focus is on mitigating treatment related toxicity in cancer survivors.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 Controlling heterogeneity within the lymphatic target volume for dose painted treatment of prostate cancerMedical Dosimetry.  45:202-205. 2020
    2020 Patient-reported cognitive complaints in older adults with gastrointestinal malignancies at diagnosis– Results from the Cancer & Aging Resilience Evaluation (CARE) studyJournal of Geriatric Oncology.  11:982-988. 2020
    2020 Assessment of Sarcopenia Measures, Survival, and Disability in Older Adults Before and After Diagnosis With CancerJAMA Network Open.  3:e204783. 2020
    2020 Metastatic prostate cancer to an ischiorectal fossa lymph node identified on multiparametric magnetic resonance imagingUrology Annals.  12:172-175. 2020
    2020 Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE)Journal of Geriatric Oncology.  11:270-273. 2020
    2020 Anchored Transponder Guided Lung Radiation TherapyPractical Radiation Oncology.  10:e37-e44. 2020
    2020 Focal Management of Large Brain Metastases and Risk of Leptomeningeal DiseaseAdvances in Radiation Oncology.  5:34-42. 2020
    2020 Lipid microsphere bound oxycodone for pain management in patients receiving radiotherapy for head and neck cancerSupportive Care in Cancer2020
    2020 Synchronous Malignancies Identified by 18F-fluciclovine Positron Emission Tomography for Prostate Cancer: Case Series and Mini-ReviewClinical Genitourinary Cancer2020
    2020 Total body irradiation and risk of breast cancer after blood or marrow transplantation: A blood or marrow transplantation survivor study reportJournal of Clinical Oncology.  38:2872-2882. 2020
    2019 Comparison of Techniques for Involved-Site Radiation Therapy in Patients With Lower Mediastinal LymphomaPractical Radiation Oncology.  9:426-434. 2019
    2019 Electromagnetic Transponder Based Tracking and Gating in the Radiotherapeutic Treatment of Thoracic MalignanciesPractical Radiation Oncology.  9:456-464. 2019
    2019 Feasibility of Dose Escalating [18F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate CancerAdvances in Radiation Oncology.  4:649-658. 2019
    2019 Stereotactic body radiotherapy in locally advanced pancreatic adenocarcinoma: A single institution experienceAnnals of Oncology.  30:iv89. 2019
    2019 Sarcopenia & aging in cancerJournal of Geriatric Oncology.  10:374-377. 2019
    2019 Patient Demographics and Referral Patterns for [F-18]Fluciclovine-PET Imaging at a Tertiary Academic Medical CenterJournal of the American College of Radiology.  16:315-320. 2019
    2019 Pathologic Predictors of Local Recurrence in Atypical Meningiomas Following Gross Total Resection 2019
    2019 Incidence of mesorectal node metastasis in locally advanced cervical cancer: its therapeutic implicationsInternational Journal of Gynecological Cancer.  29:48-52. 2019
    2019 Longitudinal assessment of anchored transponder migration following lung stereotactic body radiation therapyJournal of Applied Clinical Medical Physics.  20:17-22. 2019
    2019 Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective TrialAdvances in Radiation Oncology.  4:90-95. 2019
    2018 How Would MRI-targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer?Urology.  122:139-146. 2018
    2018 Brain dosimetry from locally advanced head and neck cancer radiotherapy: implications for neurocognitive outcomes researchActa Oncologica.  57:1589-1592. 2018
    2018 Dynamics of the vaginal wall dose in HDR interstitial brachytherapy for gynecological cancer: Systematic analysis of phantom vs patient caseMedical Dosimetry.  43:237-242. 2018
    2017 Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancerUrologic Oncology: Seminars and Original Investigations.  35:663.e15-663.e21. 2017
    2017 Fractionated stereotactic radiation therapy for intact brain metastasesAdvances in Radiation Oncology.  2:564-571. 2017
    2017 Gait Speed and Survival in Patients With Brain MetastasesJournal of Pain and Symptom Management.  54:105-109. 2017
    2017 CT measures of bone mineral density and muscle mass can Be used to predict noncancer death in men with prostate cancerRadiology.  282:475-483. 2017
    2017 Distant brain recurrence in patients with five or more newly diagnosed brain metastases treated with focal stereotactic radiotherapy alone.Journal of Radiosurgery and SBRT.  4:255-263. 2017
    2016 Long-term results of a phase I/II trial of the addition of celecoxib to chemoradiotherapy for locally advanced or recurrent squamous cell carcinoma of the head-and-neckJournal of Radiation Oncology.  5:363-369. 2016
    2016 Mesorectal node metastasis from gynecological cancer in the era of 3D conformal pelvic radiation therapy and intensity modulated radiation therapyPractical Radiation Oncology.  6:402-404. 2016
    2016 Combining Computed Tomography-Based Bone Density Assessment with FRAX Screening in Men with Prostate CancerJournal of Clinical Densitometry.  19:430-435. 2016
    2016 Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma 2016
    2016 Evaluating the Role of Urinalysis for Suspected Cystitis in Women Undergoing Pelvic Radiotherapy.International Journal of Gynecological Cancer2016
    2016 Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignanciesWorld Journal of Gastroenterology.  22:3006-3014. 2016
    2016 Pelvic radiotherapy versus radical prostatectomy with limited lymph node sampling for high-grade prostate adenocarcinomaProstate Cancer.  2016. 2016
    2015 Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy AloneJournal of Gastrointestinal Cancer.  46:149-155. 2015
    2014 Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: The University of Alabama at Birmingham experience 2014
    2014 ReplyUrology.  84:1388. 2014
    2014 Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapyRadiation Oncology.  9. 2014
    2014 An empirical assessment of two-dimensional (2D) Debye-Scherrer-type image-plate X-ray diffraction data collapsed into a 1D diffractogramPowder Diffraction.  29:337-345. 2014
    2014 PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalationUrologic Oncology: Seminars and Original Investigations.  32:687-693. 2014
    2014 Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapyUrology.  84:1383-1388. 2014
    2013 Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancerActa Oncologica.  52:1181-1188. 2013
    2013 Patient benefit from salvage radiation for prostate cancer.Journal of Clinical Oncology.  31:175. 2013
    2013 Spontaneous spinal epidural abscess presenting in a previously healthy young adult manCase Reports in Medicine.  2013. 2013
    2012 Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry.Prostate Cancer.  2012:546794. 2012
    2011 Efficacy and rectal toxicity of hypofractionated radiation therapy with daily image guidance.Journal of Clinical Oncology.  29:85. 2011

    Education And Training

  • Doctor of Medicine, University of Alabama at Birmingham 2012
  • Master of Sciences or Mathematics, University of Alabama at Birmingham 2008
  • Bachelor of Science or Mathematics, University of Alabama at Birmingham 2006
  • Birmingham Baptist Health Systems, Internship 2013
  • University of Alabama at Birmingham, Residency 2017
  • Full Name

  • Andrew McDonald